Welcome to the Medical Homepage
The Colorado Medical Board (CMB) was instituted as part of the Medical Practice Act for the purpose of regulating and controlling the practice of healing arts, which include establishing and enforcing the licensing standards for Medical Doctors (M.D.s), Doctors of Osteopathy (D.O.s), Physician Assistants (P.A.s), and Anesthesiology Assistants (A.A.s). Licensure is mandatory to practice medicine in Colorado or to treat Colorado patients. Exceptions exist for the Veterans Administration, Bureau of Indian Affairs, and Department of Defense physicians and other licensed healthcare providers.
The CMB investigates the unlicensed practice of medicine, however, it does not have authority to arbitrate or adjudicate fee disputes. The decisions made by the CMB are not subject to administrative review. The CMB is a Type I Board, meaning that it is policy autonomous and comprised of professional and public members (eight M.D.s, three D.O.s, two P.A.s, and four public members).
Program Information
- Program/Board Members
-
Paula E. Martinez, Program Director
Colorado Medical Board
1560 Broadway, Suite 1350
Denver, CO 80202Phone: 303-894-7800 | Fax: 303-894-7692 | Email: dora_medicalboard@state.co.us
Roland Flores, Jr., M.D., President
Professional Member | Term Expires: May 3, 2023Panel A:
-
Amanda Mixon, P.A.-C, Panel A Chair
Professional Member | Term Expires: May 3, 2024 -
Jennifer Blair, M.D.
Professional Member | Term Expires: May 3, 2025 -
Beckett Czarnecki
Public Member | Term Expires: May 3, 2026 -
Robert M. Maulitz, M.D.
Professional Member | Term Expires: May 3, 2025 -
Saughar Samali, D.O.
Professional Member | Term Expires: May 3, 2024 -
Alan E. Shackelford, M.D.
Professional Member | Term Expires: May 3, 2023
Panel B:
-
Kiely M. Schultz, D.O., Panel B Chair
Professional Member | Term Expires: May 3, 2026 -
Amy E. Colen, Panel B Vice President
Public Member | Term Expires: May 3, 2023 -
Anita Kumar, M.D.
Professional Member | Term Expires: May 3, 2026 -
Donald J. Lefkowits, M.D.
Professional Member | Term Expires: May 3, 2023 -
Maidul (May) Mehmud
Public Member | Term Expires: May 3, 2026 -
Kian A. Modanlou, M.D.
Professional Member | Term Expires: May 3, 2024
Licensing Panel
-
Scott C. Strauss, D.O., FAAFP, Licensing Panel Chair
Professional Member | Term Expires: May 3, 2025 -
Christopher A. Bates, M.D.
Professional Member | Term Expires: May 3, 2025 -
Julie Ann Harper, P.A.-C
Professional Member | Term Expires: May 3, 2025 -
Hien (Adam) H. Ly
Public Member | Term Expires: May 3, 2024
-
- Public Notices
-
Permanent Rulemaking Hearing - November 17, 2022
The Colorado Medical Board will hold a Permanent Rulemaking Hearing to allow stakeholders a final opportunity to provide testimony before the Board considers adopting multiple proposed new and revised rules to implement Colorado Senate Bill 22-116 (Concerning the ability of an individual to obtain an occupational credential through the occupational credential portability program); Colorado House Bill 22-1115 (Concerning the Prescription Drug Monitoring Program); Colorado House Bill 22-1284 (Concerning updates to state surprise billing laws to facilitate the implementation of surprise billing protections, and aligning state law with the federal "No Surprises Act"); Executive Order D 2022-032 (Directing State Agencies to Protect Access to Reproductive Health Care in Colorado); and Executive Order D 2022-034 (Protecting Colorado’s Workforce and Expanding Licensing Opportunities).
- Thursday, November 17, 2022, at 1:00 P.M. (MDT)
- Webinar Registration
- Sign up to Testify
- Notice, Draft Rules, SB22-116, HB22-1115, HB22-1284, EO D 2022-032, and EO D 2022-034
- Written Comments
- SB22-116 Joint Stakeholder Meeting: June 10, 2022
- EO D 2022-032 Joint Stakeholder Meeting: July 22, 2022
- EO D 2022-034 Joint Stakeholder Meeting: July 29, 2022
- HB22-1284 Joint Stakeholder Meeting: August 12, 2022
- HB22-1115 Joint Stakeholder Meeting: August 29, 2022
Emergency Rulemaking Hearing - October 6, 2022
The Colorado Medical Board will hold an Emergency Rulemaking Hearing to allow stakeholders a final opportunity to provide testimony before the Board considers adopting new Rules 161 (3 CCR 713-51) and 162 (3 CCR 713-52), to implement Executive Order D 2022-032 (Directing State Agencies to Protect Access to Reproductive Health Care in Colorado); and Executive Order D 2022-034 (Protecting Colorado’s Workforce and Expanding Licensing Opportunities). The Board will consider emergency adoption of Rules 161 (3 CCR 713-51) and 162 (3 CCR 713-52) to comply with the reporting requirements of the Executive Orders.
- Thursday, October 6, 2022, at 9:00 A.M. (MDT)
- Webinar Registration
- Sign up to Testify
- Notice, Draft Rules, EO D 2022-032, and EO D 2022-034
- (EO D 2022-034) Joint Stakeholder Meeting: July 29, 2022
- (EO D 2022-032) Joint Stakeholder Meeting: July 22, 2022
Stakeholder Meeting - May 19, 2022
The Colorado Medical Board will hold a Permanent Rulemaking Hearing to allow stakeholders a final opportunity to provide testimony before the Board considers adopting the proposed revisions to Rules 130 (3 CCR 713-28), 410 (3 CCR 713-29), and 520 (3 CCR 713-42), to implement Colorado House Bill 20-1326 (Concerning an expansion of an individual's ability to practice an occupation in Colorado through creation of an occupational credential portability program).
- Thursday, May 19, 2022, at 10:00 A.M. (MDT)
- Webinar Registration
- Sign up to Testify
- Notice, Draft Rules, and HB20-1326
- HB20-1326 Stakeholder Meeting: August 9, 2021
- HB20-1326 and HB21-1276 Stakeholder Meeting: October 25, 2021
- HB20-1326 Stakeholder Meeting: January 7, 2022
- HB20-1326 Stakeholder Meeting: April 11, 2022
Permanent Rulemaking Hearing - February 17, 2022
The Colorado Medical Board held a Permanent Rulemaking Hearing on February 17, 2022, that allowed stakeholders a final opportunity to provide testimony before the Board considered adopting the proposed revisions to Rule 120 (3 CCR 713-22), to implement Colorado House Bill 20-1326 (Concerning an expansion of an individual's ability to practice an occupation in Colorado through creation of an occupational credential portability program).
- Notice, Draft Rule, Written Comments, and HB20-1326
- Effective Date: April 14, 2022
Joint Stakeholder Meeting - February 14, 2022
The State Board of Pharmacy (Board) held a Joint Stakeholder Meeting that allowed stakeholders from the State Board of Pharmacy, Colorado Medical Board, and State Board of Nursing an opportunity to provide feedback on the proposed revisions to the Statewide Protocol for Prescribing Hormonal Contraceptive Patches and Oral Contraceptives (Appendix A), and the Colorado Self-Screening Contraception Risk Assessment Questionnaire to include Vaginal Rings and Depot Medroxyprogesterone Acetate (DPMA). Additionally, updates to the Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use, embedded in Appendix A of the Board’s rules, are proposed to align the rules with recent updates from the Centers for Disease Control and Prevention (CDC).
Stakeholder Meeting - January 7, 2022
The Colorado Medical Board held a virtual Stakeholder Meeting on January 7, 2022, that allowed stakeholders an opportunity to provide feedback on the implementation of Colorado House Bill 20-1326 (Concerning an expansion of an individual's ability to practice an occupation in Colorado through creation of an occupational credential portability program); and the subsequent proposed revisions to Rules 120 (3 CCR 713-22), 130 (3 CCR 713-28), 410 (3 CCR 713-29), and 520 (3 CCR 713-42).
- Notice, Draft Rules, and HB20-1326
- HB20-1326 Stakeholder Meeting (recording): August 9, 2021
- HB20-1326 and HB21-1276 Stakeholder Meeting (recording): October 25, 2021
- HB20-1326 Stakeholder Meeting (recording): January 7, 2022
Permanent Rulemaking Hearing - May 20, 2021
The Colorado Medical Board held a Permanent Rulemaking Hearing that allowed stakeholders a final opportunity to provide feedback before the Board considered adopting revisions to Rule 170, to correct language in the rule that conflicted with portions of the statute in section 12-30-115, C.R.S., of Colorado Senate Bill 20-102 (Concerning required disclosures to patients regarding formal actions based on sexual misconduct)
- Notice, Draft Rule, and SB20-102
- Joint Stakeholder Meeting (SB20-102): February 11, 2021
- Effective Date: July 15, 2021
Permanent and Emergency Rulemaking Hearing - November 18, 2021
The Colorado Medical Board held a Permanent and Emergency Rulemaking Hearing on November 18, 2021, that allowed stakeholders a final opportunity to provide testimony on the implementation of Colorado House Bill 20-1326 (Concerning an expansion of an individual's ability to practice an occupation in Colorado through creation of an occupational credential portability program); Colorado House Bill 21-1276 (Concerning the prevention of substance use disorders); and the subsequent proposed revisions to Rule 120 (3 CCR 713-22) to implement HB20-1326, and the proposed new rule (3 CCR 713-49) to implement HB21-1276 - which will be considered for permanent and emergency adoption to comply with the legislative mandate. The Board did not adopt revisions to Rule 120 (3 CCR 713-22) during this hearing, those revisions will be considered at the next Board Meeting on February 17, 2022.
- Notice, Stakeholder Comments, HB20-1326, HB21-1276, and Draft Rules
- HB21-1276 Joint Stakeholder Meeting (recording): July 23, 2021
- HB22-1309: Hospital Dispense Drugs To Sexual Assault Victims
- HB20-1326 Stakeholder Meeting (recording): August 9, 2021
- Stakeholder Meeting (recording): October 25, 2021
- HB21-1276 Emergency Rule Effective Date: November 18, 2021
- HB21-1276 Permanent Rule Effective Date: January 14, 2022
Joint Stakeholder Meeting - October 15, 2021
The State Board of Pharmacy, State Board of Nursing, Colorado Medical Board, Colorado Dental Board, Colorado Podiatry Board, State Board of Veterinary Medicine, and State Board of Optometry held a Joint Stakeholder Meeting to gather feedback to identify and create a list of prescription drugs and substances (using evidence-based practices), in addition to controlled substances, that have a substantial potential for abuse and must require pharmacists and prescription drug outlets to report those prescription drugs and substances to the Prescription Drug Monitoring Program (PDMP) when dispensed to a patient. The Board is considering the development of new rules to monitor non-controlled prescription drugs/substances, as allowed per section 12-280-404(2)(b)(I), C.R.S., of Colorado Senate Bill 21-098.
- Notice and SB21-098
- Joint Stakeholder Meeting (recording): October 15, 2021
- Legislative Updates
-
- 2022 New Legislation
- HB22-1041: Privacy Protections For Protected Persons
- HB22-1050: International Medical Graduate Integrate Health-care Workforce
- HB22-1098: Department Of Regulatory Agencies Barriers To Practice Regulated Professions
- HB22-1115: Prescription Drug Monitoring Program
- HB22-1165 Rule Review Bill
- HB22-1240 Mandatory Reporters
- HB22-1256 Modifications To Civil Involuntary Commitment
- HB22-1257: 2022 Criminal And Juvenile Justice Commission Recommendations
- HB22-1267 Culturally Relevant Training Health Professionals
- HB22-1270 Change Term Name-based Criminal History Record Check
- HB22-1278: Behavioral Health Administration
- HB22-1284: Health Insurance Surprise Billing Protections
- HB22-1291: Sunrise Review Professions Occupations
- HB22-1326: Fentanyl Accountability And Prevention
- SB22-013: Boards and Commissions
- SB22-027: Prescription Drug Monitoring Program
- SB22-076: Complaint Occupational License Official Acts
- SB22-116: Increase Occupational Credential Portability
- SB22-140 Expansion Of Experiential Learning Opportunities
- SB22-143: Update Common Provision Term Regulator Title 12
- SB22-162: Administration Organization Act Modernization
- SB22-174: Sunset Review Hearing
- SB22-226: Programs To Support Health-care Workforce
- Criteria
- 2021 New Legislation
- HB21-1198: Healthcare Billing Requirements for Indigent Patients
- HB21-1021: Peer Support Professionals Behavioral Health
- HB21-1012 Expand Prescription Drug Monitoring Program
- HB21-1022: Surrogacy Agreements
- HB21-1068: Insurance Coverage Mental Health Wellness Exam
- HB21-1119: Suicide Prevention, Intervention, & Postvention
- HB 21-1123: CAPS Check for Substantiated Cases of Mistreatment of an At-Risk Adult
- HB21-1130: Expand Transition Specialist Program
- HB21-1143: Protect Survivors' Rights To Rape Kit Evidence
- HB21-1169: Prohibit Discrimination Organ Transplant Recipient
- HB21-1190: Defining Telemedicine for Medical Practitioners
- HB21-1232: Standardized Health Benefit Plan Colorado Option
- HB21-1276: Prevention of Substance Use Disorders
- HB21-1297: Pharmacy Benefit Manager and Insurer Requirements
- HB21-1300: Health-care Provider Liens for Injured Persons
- HB21-1307: Prescription Insulin Pricing And Access
- HB21-1317: Regulating Marijuana Concentrates
- SB21-009: Reproductive Health Care Program
- SB21-011: Pharmacist Prescribe Dispense Opiate Antagonist
- SB21-016: Protecting Preventive Health Care Coverage
- SB21-056 Expand Cannabis-based Medicine At Schools
- SB21-077: Remove Lawful Presence Verification Credentialing
- SB21-094: Sunset Continue State Board of Pharmacy
- SB21-097: Sunset Medical Transparency Act
- SB21-098: Sunset Prescription Drug Monitoring Program
- SB21-122: Opiate Antagonist Bulk Purchase And Standing Orders
- SB21-142: Health Care Access In Cases Of Rape Or Incest
- SB21-193: Protection of Pregnant People In Perinatal Period
- SB21-194: Maternal Health Providers
- SB21-195: Notarization of Certain Probate Documents
- SB21-271: Misdemeanor Reform
- SB21-292: Federal COVID Funding for Victim's Services
- 2020 New Legislation
- 2022 New Legislation
- Meeting Minutes
-
Full Board Meeting Minutes
- May 19, 2022, Medical Board Meeting Minutes
- February 17, 2022, Medical Board Meeting Minutes
- November 18, 2021, Medical Board Meeting Minutes
Licensing Panel Meeting Minutes